Replimune Group, Inc. (REPL)

6.89 +0.13 (+1.92%) USD  |  NASDAQ  |  Mar 19, 16:00
7.03 +0.14 (+2.03%) Pre-Market: 09:14
More

Replimune Group EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
REGENXBIO, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Mirum Pharmaceuticals, Inc. --